Single Center Study of Clinical Features and Prognostic Analysis of Neuroblastic Tumor in Children
Xiao Hui,Guo Xia,Wan Zhi,Ai Yuan,Yang Xue,Sun Shuwen,Jiang Mingyan,Gao Ju
DOI: https://doi.org/10.3760/cma.j.issn.1673-419x.2017.05.002
2017-01-01
Abstract:Objective To analyze the clinical features and clinical outcomes of pediatric neuroblastic tumor(NT),and to document prognosis-related risk factors of pediatric NT.Methods From January 2010 to June 2016,clinical data of 34 new-onset pediatric NT patients were enrolled in this study.Their general clinical data,results of auxiliary examination,primary site and metastasis site,pathological type,MYCN amplification test results,clinical stage and risk group,treatment,efficacy and prognosis of patients with pediatric NT were analyzed retrospectively.Two-year event-free survival (EFS) rates and overall survival (OS) rates were calculated by the Kaplan-Merire method.Univariable analysis by log-rank test was undertaken to identify prognosis-related influence factors and multivariable analysis by the Cox proportional hazards regression model was for independent prognosis-related influence factors.The study protocol was approved by the Ethical Review Board of Investigation in Human Being of West China Second University Hospital,Sichuan University.Results ① Among 34 pediatric NT patients,there were 13 male patients (38.2％) and 21 female patients (61.8％).Median age of them at diagnosis was 40.5 months,with 28 cases having age of onset over 18 months.Abdominal mass (50.0％,17/34),fever (32.3％,11/34)and abdominal pain (32.3％,11/34) were the leading causes of seeking medical care.(②) Among 34 pediatric NT patients,28 cases (82.3 ％) were primary abdominal mass,6 cases (17.6 ％) occurred in non-abdomen.At diagnosis,there were 16 cases (47.0％) with bone marrow metastasis,10 cases (29.4％) with skeletal metastasis,3 cases (8.8 ％) with cervical lymph nodes metastasis,while spleen and lung metastasis occurred both in one case (2.9％).③ Routine blood test results showed 18 cases (52.9％) had anemia.Seventeen cases finished serum neuron-specific enolase (NSE) test,whose serum NSE level were 27.28-370.00 ng/mL.④ The maximum diameter of the primary tumors in 14 cases were over 9 centimeters.The imaging examination of the study showed 18 cases (52.9％) had adrenal region masses,10 cases (29.4％)had retroperitoneal cavity masses,4 cases (11.8％) had mediastina masses,one case (2.9％) had neck mass,one case (2.9 ％) had pelvic cavity mass.(⑤ Among 34 pediatric NT patients,pathology diagnosis of 24 cases (70.6％) were neuroblastoma (NB) and 10 cases (29.4％) were ganlioneuroblastoma (GNB).⑥) MYCN amplification was identified in 11 out of 30 cases (36.7％).These 11 patients with MYCN-amplified were exclusively stage Ⅲ-Ⅳ and categorized as high-risk or very-high risk.⑦ Among 34 pediatric NT patients,there were 2 cases (5.9％) at stage Ⅰ,4 cases (11.8％) at stageⅡ,10 cases (29.4％) at stage Ⅲ,18 cases (52.9％) at stage Ⅳ.Three cases (8.8％) were categorized in low-risk group,6 cases (17.6％) in media-risk group,10 cases (29.4％) in high-risk group,15 cases (44.1％) in very-high risk group.⑧ A total of 28 cases (82.4 ％) received surgery before chemotherapy,and 6 cases (17.6 ％) received 3-4 cycles chemotherapy before surgery.The 2-year EFS and 2-year OS rates of the 34 pediatric NT patients were 50.0％ and 67.6％,respectively.(⑨) Univariable analysis results showed,stage Ⅲ-Ⅳ,non-resection or incomplete tumor resection before combination chemotherapy,high-risk and very-high risk group,and MYCN amplification were associated with inferior 2-year EFS rates compared to stage Ⅰ-Ⅱ,complete tumor resection,low-risk and middle-high risk group and non-MYCN-amplified (x2 =7.697,6.048,5.695,5.125;P=0.006,0.014,0.015,0.025).⑩ Multivariable analysis by the Cox proportional hazards regression model disclosed that risk group (OR=46.340,95 ％ CI=2.764-777.065,P=0.008) and extent of surgical excision before chemotherapy (OR=3.668,95％CI=1.209-11.133,P=0.022) were independent adverse prognostic risk factors.Conclusions NT is clinically characterized by tumor onset at early childhood,great tendency of early multisite or multifocal distant metastasis,presenting with advanced tumor stage at diagnosis.MYCN amplification which predominantly seen in advanced stage and high-risk NT,is an adverse biological prognostic risk factor essential to refined risk group of NT.Prognosis remains to be quite poor in high-risk and particularly very-high risk NT,with strikingly high mortality rate in high and very-high risk group.